Prosecution Insights
Last updated: May 29, 2026

Examiner: NGUYEN, JOHN P

Tech Center 1600 • Art Units: 1619

This examiner grants 44% of resolved cases

Performance Statistics

44.5%
Allow Rate
-15.5% vs TC avg
441
Total Applications
+41.6%
Interview Lift
1172
Avg Prosecution Days
Based on 402 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
2.7%
§102 Novelty
80.5%
§103 Obviousness
3.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19342419 FABRIC MATERIAL INFUSED OR IMPREGNATED WITH ONE OR MORE BENEFICIAL AGENTS AND METHOD OF MAKING THEREOF Non-Final OA BIO PROTECTANT TECHNOLOGIES, INC.
18525039 METHODS OF ANTIBODY PRODUCTION Non-Final OA AMGEN INC.
17054441 SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY Non-Final OA NORTHWESTERN UNIVERSITY
17636209 Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders Final Rejection Arizona Board of Regents on behalf of Arizona State University
17235771 BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17306490 METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE Final Rejection AltaThera Pharmaceuticals LLC
18413456 COMPOSITIONS AND METHODS FOR TREATING FLATWORMS Non-Final OA New Guinea Flatworm Spray, Inc.
18001896 TREATMENT OF ATRIAL DYSFUNCTION Non-Final OA MyoKardia, Inc.
18188899 COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS Non-Final OA Pearl Therapeutics, Inc.
18247637 METHODS OF TREATING BONE INFECTIONS Non-Final OA MICROBION CORPORATION
18269421 PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS Non-Final OA HK INNO.N CORPORATION
18264815 HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY Non-Final OA NIHON TRIM CO., LTD.
18128866 WOUND HEALING AND TISSUE REPAIR COMPOSITION AND METHOD USING LOW MOLECULAR WEIGHT COLLAGEN AND BIOACTIVE GLASS Non-Final OA SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
18124977 Window of Opportunity Skin Treatment Regimen and Composition for Preventing the Onset of or Treating Atopic Dermatitis Non-Final OA UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND
17920984 COMPOSITIONS AND METHODS FOR TREATING UPPER RESPIRATORY INFECTIONS Non-Final OA SaNOtize Research and Development Corp.
18001582 Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents Final Rejection APHAIA IP AG
17784053 TOPICAL DELIVERY OF RNA INTERFERENCE AGENTS USING IONIC LIQUID Final Rejection CAGE BIO, INC.
17441915 HYALURONIC ACID SKIN CARE COMPOSITION AND PREPARATION METHOD AND APPLICATION THEREOF Final Rejection BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month